Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 13 | 26 | 0 | 0 |
| Accounts receivable | 5 | -47 | N/A | N/A | -4 |
| Accounts payable and accrued liabilities | -158 | N/A | N/A | N/A | 130 |
| Other Working Capital | -203 | -108 | N/A | N/A | 131 |
| Other Operating Activity | 138 | -402 | -42 | -201 | -388 |
| Operating Cash Flow | $-205 | $-544 | $-16 | $-201 | $-130 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | N/A | 742 | 0 | N/A |
| Sale Of Investment | 0 | 0 | 0 | 8 | 38 |
| Investing Cash Flow | $0 | $0 | $741 | $8 | $38 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | N/A | 100 |
| Common Stock Issued | 0 | 326 | N/A | N/A | 0 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -7 |
| Financing Cash Flow | $0 | $326 | $N/A | $N/A | $93 |
| Exchange Rate Effect | 0 | 0 | 1 | 1 | 1 |
| Beginning Cash Position | 342 | 560 | 160 | 10 | 8 |
| End Cash Position | 138 | 342 | 560 | 160 | 10 |
| Net Cash Flow | $-205 | $-218 | $399 | $149 | $1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205 | -544 | -16 | -201 | -130 |
| Free Cash Flow | -205 | -544 | -16 | -201 | -130 |